Page 3 - Jack Anders News Today

Revolution Medicines (NASDAQ:RVMD – Free Report) had its price objective upped by Oppenheimer from $35.00 to $40.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. Oppenheimer currently has an outperform rating on the stock. Several other equities analysts also recently issued reports on RVMD. HC Wainwright reissued a buy rating and set […]

Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They currently have a $32.00 price target on the stock. HC Wainwright’s price objective would suggest a potential downside of 2.38% from the […]

Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) has received a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month price objective among […]

Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month […]

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Rating) CFO Jack Anders sold 1,249 shares of the stock in a transaction on Tuesday, June 20th. The stock was sold at an average price of $24.89, for a total transaction of $31,087.61. Following the transaction, the chief financial officer now owns 55,094 shares in the company, valued at […]

Operator: Good day and welcome to Revolution Medicines First Quarter 2023 Earnings Conference Call. As a reminder, todays conference is being recorded.

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Rating) CFO Jack Anders sold 665 shares of Revolution Medicines stock in a transaction that occurred on Friday, March 17th. The stock was sold at an average price of $21.78, for a total transaction of $14,483.70. Following the completion of the transaction, the chief financial officer now directly owns […]

Operator: Good day, and thank you for standing by. Welcome to the Revolution Medicines Q4 Year-End 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.

A look at Florida's additions via the transfer portal.

Operator: Good day and thank you for standing by. Welcome to the Revolution Medicines Third Quarter 2022 Earnings Webcast.